[Sequential infusion of anti-CD22 and anti-CD19 CAR-T cells in the treatment of relapsed / refractory childhood acute B lymphoblastic leukemia: two cases report].

Zhang, J; Wu, X X; Li, M Y; Song, B Q; Zhou, L L; Kong, X; Qiu, H Y; Wu, D P

Zhang, J; Wu, X X; Li, M Y; Song, B Q; Zhou, L L; Kong, X; Qiu, H Y; Wu, D P.

Affiliation

Zhang J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Wu XX; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Li MY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Song BQ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Zhou LL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Kong X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Qiu HY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.
Wu DP; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hematology Department, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Suzhou 215006, China.

Zhonghua Xue Ye Xue Za Zhi ; 43(3): 258, 2022 03 14.

Article in Zh | MEDLINE | ID: mdl-35405786

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antigens, CD19 / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Child / Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google